2015 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |

AHIA National Conference 2005

8 November 2005

Click here to download the full detailed program. (1.33 MB PDF)

AHIA National Conference 2005

The Pathway to Sustainable Affordability

8-10 November 2005

The AHIA 2005 Conference considered the future of Health Insurance in Australia and the increasing challenges faced by health funds to provide an affordable and quality product to the consumer. Issues that were addressed included:

strategies for change for addressing an ageing population
chronic diseases
growing membership
the impact of medical technology and innovation on costs

Conference Presentations

Click on each of the speaker’s name below to download their presentations in PDF version. Presentation downloads are available for all invited speakers that have approved their work for web publication.

Session	Topic	Speakers and Presentations	Overview
DAY ONE
1	Sustainable affordability in health care financing & delivery	Bernard J Tyson, Senior Vice President, Brand Strategy and Management, Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals (5.1 MB ppt)	Sustainable affordability in health care financing and delivery from the perspective of Kaiser Permanente The challenges to sustainable health care financing and delivery Achievement and current challenges of Kaiser Permanente Private sector solutions to affordable health care delivery Improving the efficiency and quality of health care Developing patient-centred care Implications for private health insurance in Australia
2	Sustainable affordability – Australian and New Zealand experiences with Private Health Insurance	Professor Ian Harper, Executive Director, Melbourne Business School (91 KB ppt)	The Benefits of Private Health Insurance Effect of the rebate on public hospital waiting lists Private health insurance and sustainable affordability in Australia
2		Dr Ian McPherson, Chief Executive Officer, Southern Cross Healthcare, New Zealand (2.2 MB ppt)	Update on the role of private health insurance in New Zealand The challenge of sustainability for Southern Cross Health Fund Private health insurance innovations Medical savings accounts Implications for private health insurance in Australia
3	Chronically ill patients – Health fund approaches to coordination of care and self management	Bruce Levy, Group Manager, Health Services, Medibank Private	Chronic Care Initiatives at Medibank Private Medibank Private’s approach to chronic care
		Virginia Haggar, Director-Education, International Diabetes Institute	A provider perspective The results of Medibank-on-Track Program – diabetes management pilot
		Keith Finney, General Manager, Provider & Procurement, BUPA Australia Health	BUPA’s approach to chronic care A clinician’s perspective Patient perspective: how AuseMed has helped
4	Responses to providing better quality health care at an affordable cost; The potential for more effective use of data	DR Martin Van Der Weyden, Editor, The Medical Journal of Australia	Safety in Australian Healthcare: who cares? The safety of Australian Health Care – QAHCS Study, sentinel events, incidents and scandals The need for reform Clinical workforce shortages and health care financing challenges Role of Australian Council for Quality & Safety in Health Care Urgent areas for action Implications for private health insurance
		The Hon DR Michael Wooldridge	The mixed public/private Australian health system Overview of Australian health and health service indicators and international comparative data Using data to improve health services Barriers to linking data and establishing effective databases in Australia
		Professor Peter Collignon, Director, Infectious Diseases Unit, The Canberra Hospital (Presentation delivered by Professor Lindsay Grayson, Infectious Diseases Department, Austin Health and Department of Medicine, University of Melbourne) (10.2 MB ppt)	The extent of health care associated infections in Australian hospitals Staphylococcus aureus and MRSA Trends and outlook Clinical presentation of patients High risk patients National strategies for prevention Data collection and monitoring Impact on health care quality, patient outcomes and costs
DAY TWO
5	An ageing Australia: Implications for health expenditure and private health insurance	Bernard Salt, Partner, KPMG (2.2 MB ppt)	Demographic trends and an ageing Australia Current outlook Health expenditure and health insurance implications
		Rhonda Parker, Chief Executive, Positive Ageing Foundation of Australia (261 KB ppt)	Research findings on the impact of ageing Trends Healthy ageing Needs of mature people Services and programs to promote successful ageing Implications for health insurers
		Professor Allan McLean, Director, National Ageing Research Institute (2.6 MB ppt)	The biology of ageing Cause, prevention and cure of disease Consequences of ageing and its social accompaniments Lessons for health insurers
6	Musculoskeletal disease and injury, treatment and rehabilitation	Professor Stephen Graves, Director, Australian Orthopaedic Assoc. National Joint Replacement Registry (926 KB ppt)	The Scope of Musculoskeletal Disease – Treatment and Costs The scope of musculoskeletal disease Incidence, prevalence, extent of the disease Trends and implications for treatment and coverage Cost implications Patient management Joint replacement Improving health outcomes and reducing cost.
6		DR Marlene Fransen, Senior Research Fellow, Injury Prevention and Trauma Care, The George Institute for International Health, University of Sydney (12 MB ppt)	Extent of knee replacement operations in Australia Trends Demographics Post-operative recovery and rehabilitation outcomes Cost-effectiveness and scientific evidence Implications for private health insurance
7	Can we keep pharmaceutical costs affordable and new medicines viable?	Professor Andrew Wilson, Chair, Economic Committee, Pharmaceutical Benefits Advisory Committee, DoHA (148 KB ppt)	Overview of the Pharmaceutical Benefits Scheme Special Access and High Cost Drugs Current coverage and expenditure Future trends Impact of new technologies and high cost drugs Drugs in the pipeline Role of PBAC Evaluation methods used in PBAC decision-making Implications for private health insurance
8	The ACCC view of key competition issues impacting on the Private Health Sector	John Martin, Commissioner, Australian Competition and Consumer Commission (326 KB ppt)	The ACCC approach to approval of recent large merger proposals, such as Ramsay/Affinity Update on ACCC’s monitoring of anti-competitive practices impacting on private health insurance ACCC view of sustainable affordability and whether hospital mergers and takeovers result in lower prices for consumers Competition, health funds and the privatisation of Medibank Private Future outlook for the private health sector from the ACCC viewpoint

Back to top